LuxUrban Hotels Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 12, 2024 deadline
April 08, 2024 18:54 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises LuxUrban Hotels Inc....
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
April 08, 2024 16:01 ET
|
Kineta, Inc.
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts Favorable clinical safety and tolerability profile observed with no dose...
LuxUrban Hotels Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 12, 2024 deadline
April 03, 2024 19:22 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 03, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises LuxUrban Hotels Inc....
2023 Earnings Report
April 03, 2024 12:00 ET
|
SOLUTIONS 30
Margin growth is proving solidAdjusted EBITDA up significantly (+59.6%) Revenue has shown healthy growth, topping the billion euro mark €1.057 billion in revenue in 2023, in line with...
Informa PLC Confirms Dates for FinovateSpring 2024
April 03, 2024 09:35 ET
|
Finovate
SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) -- via NetworkWire -- Informa PLC (“Informa”), a London-based events production, digital products and academic research services agency, is pleased to...
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
April 02, 2024 08:30 ET
|
Vaccinex, Inc.
Expect Topline Data for Randomized SIGNAL-AD Study of Pepinemab for Alzheimer’s Disease in Q3 2024. $17.9 million of new financing in Q4 2023 and Q1 2024.
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024 09:00 ET
|
Adagene Inc.
- Data for masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable (MSS) colorectal cancer...
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
March 27, 2024 07:30 ET
|
PDS Biotechnology Corporation
Unique mechanism of action of the combination of PDS01ADC and Versamune® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company to...
Indonesia Construction Equipment Rental Industry Report 2024: Strategic Assessment & Forecasts 2023-2029 with Machinery, Kobelco, Zoomlion, XCMG, SANY, and Volvo Dominating
March 22, 2024 05:13 ET
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Indonesia Construction Equipment Rental Market - Strategic Assessment & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's...
Nano Dimension Announces Record 2023 Revenue of $56.3 Million and Organic Growth of 29%
March 21, 2024 07:30 ET
|
Nano Dimension Ltd.
Gross Margin Grew 41%; 45% vs. 32% Year-Over-Year Q4/2023 Revenue Grew 19% vs. Q4/2022 Conference Call to be Held Today at 9:00 AM EDT WALTHAM, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Nano...